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ABSTRACT 
Objective: This work focused on the development of floating alginate beads for stomach specific delivery of Metronidazole towards the effective 
eradication of Helicobacter pylori, a major causative agent of peptic ulcers. 
Methods: Different formulations of sunflower oil entrapped gel beads were prepared by emulsion gelation technique using sodium alginate as 
gelling agent. The prepared beads were evaluated for size, surface morphology, drug entrapment efficiency, in vitro floatuing and in vitro drug 
release properties. 
Results: It was found that the percentage of oil plays an important role in controlling the floating of oil-entrapped alginate beads. All batches of 
beads floated for >24 hours with a very short lag time of 151–187 seconds. Scanning electron microscopy (SEM) revealed that the beads were 
spherical in shape with small pores on the surface. SEM of the cross section of the beads demonstrated minute oil globules throughout the inner 
portion of the beads confirming oil entrapment. The results clearly indicated that amount of polymer (% w/v) and amount of sunflower oil (% v/v) 
affected the bead size, floating, encapsulation efficiency and drug release of the beads. It was observed that the drug release kinetics was best fitted 
with the Higuchi model and drug release from the polymer matrix system was non fickian (anomalous transport) type. 
Conclusion: The results provide evidence that formulated gel beads may be used to incorporate antimicrobials like Metronidazole and may be 
effective when administered locally in the stomach to cure Helicobacter pylori infection. 
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INTRODUCTION 
Helicobactor pylori (H. pylori) is a small, spiral, microaerophilic, 
gram-negative bacteria with a 4-6 bulbous tipped sheathed flagella 
at one end, which helps it to penetrate the gastric mucosa and 
colonize on the gastric antrum.[1,2]  
Although H. pylori is highly sensitive to most antibiotics, it’s 
eradication from patients is very difficult, even with the current best 
therapies.[3,4] Conventional tablets or capsules are, in general, used 
for eradication therapy, but these preparations do not remain in the 
stomach for the long time. Therefore, it is difficult to reach minimum 
inhibitory concentrations in the gastric mucus where H. pylori 
colonize.  
The bacteria penetrate the gastric mucus layer and fix itself to 
various phospholipids and glycolipids in the mucus gel. Therefore, 
access of antimicrobial drugs to the site is restricted from both the 
lumen of the stomach and the gastric blood supply. To overcome the 
problems in H. pylori treatment, a novel drug delivery system that 
will localize the antibiotic at the site of infection to achieve 
bactericidal concentration is highly desirable. Floating drug delivery 
systems have a bulk density lower than gastric fluids and thus 
remain buoyant in the stomach for a prolonged period of time, 
without affecting the gastric emptying rate.  
While the system is floating on the gastric contents, the drug is 
released slowly at a desired rate from the system and remaining 
part of the residual system is slowly emptied from the stomach and 
enhanced GRT of the drug.[5-7] The extended retaintion of the drug 
can maintain a higher antibiotic concentration in the gastric region 
where H. pylori exists and thereby improve the therapeutic efficacy. 
Based on this concept, in order to enhance the efficacy, we have 
made an attempt to develop oil entrapped floating alginate beads for 
stomach site specific delivery of Metronidazole for treatment of H. 
pylori infection. It is a nitroimidazole antibiotic used particularly for 
anaerobic bacteria and protozoa. It is indicated for the treatment of 
Helicobacter pylori infection. As part of a multi-drug regimen and is 
usually taken two or three times a day. The polymer used sodium 
alginate is an inexpensive, nontoxic product extracted from kelp. 
Literature reports indicate widespread use of sodium alginate for 
achieving sustained release of drugs,[8] targeting gastric mucosa,[9] 
and increasing the bioavailability of drugs[10]. Additionally it also 
reduces interfacial tension between an oil and water phase and is 
efficient for preparation of the emulsion. 
MATERIALS AND METHODS 
Materials 
Sodium alginate (low viscosity grade; 250 cp of 2% solution at 25°C) 
was purchased from Loba Chemie Pvt. Ltd., Mumbai, India. 
Metronidazole was supplied by BS traders, Liluah, Howrah, India. 
Sunflower oil was purchased from Agro Tech Food Ltd., 
Secundrabad, India. Calcium chloride dihydrate (CCD) and 
Hydrochloric acid (35% GR) were purchased from E. Merck India 
Ltd., Mumbai, India. All materials were used with no further 
purification. Deionized water was used throughout the study. 
Preparation of floating beads 
Calcium alginate gel beads were prepared by emulsion gelation 
method. At first, the aqueous slurry of sodium alginate and 
Metronidazole in double distilled water was prepared. Sunflower oil 
was added drop wise to the aqueous slurry with stirring at 2500 
rpm by a PMDC stirrer (RQ-121/D, Remi, India) fitted with stirring 
shaft (6×250 mm) with pitched-blade-type impeller.  
The stirring was continued for 45 minutes to get a stable o/w type 
emulsion. Finally this emulsion was dropped through 18 G needle in 
to 10%w/v calcium chloride dihydrate (CCD) solution to get 
spherical beads. These beads were kept in contact with CCD solution 
for 15 minutes and then removed from CCD solution by straining, 
washed, dried in a hot air oven and stored in desicator for further 
study. The formulation variables are given in table 1. 
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Evaluation of the floating beads 
Determination of bead size 
The diameters of the dried beads were measured by Dial calipers 
[AEROSCAPE (150 X 0.2 mm)]. 
Morphology study 
Morphological examination of the surface and internal structure of 
the beads was performed by using scanning electron microscope 
(SEM). The samples placed on the stubs using a carbon adhesive 
tape, coated with gold palladium alloy using a fine coat ion sputter 
(JEOL, fine coat ion sputter JFC-1100) and then surface topography 
was analyzed under scanning electron microscope (JSM 6100 JEOL, 
Tokyo, Japan) operated at an acceleration voltage of 15 kV. 
 
Table 1: Formulation compositions for the preparation of drug 









CaCl2 .2H2 O 
(%w/v) 
F1 3 400 5.00 10 
F2 3 400 6.66 10 
F3 5 400 5.00 10 
F4 5 400 6.66 10 
 
Percentage drug entrapment efficiency 
A 100 mg portion of dried beads were placed into 100 ml of 0.1 N 
HCl. It was shaken for 6 hours and the resulting solution was 
filtered. The filtrate was suitably diluted and analyzed at 272.5 nm 
using a UV Spectrophotometer (UV-1700; SHIMADZU). The 
entrapment efficiency was calculated by the formula:  
%Entrapment efficiency = (Calculated drug concentration/ 
Theoretical drug concentration) x 100 
In vitro evaluation of floating ability 
The in vitro buoyancy study for the beads was tested by visual 
observation in 0.1 N HCl. The experiment was carried out using a 
USP dissolution apparatus II, Veego. Twenty beads of each batch 
were placed into 500 ml 0.1 N HCl maintained at 37±0.5°C and 50 
rpm. The time taken for the beads to float at the surface of the 
medium (known as floating lag time) and duration of floating were 
noted. 
In vitro drug release study 
In vitro drug release studies were carried out for all products and 
for the pure drug in USP dissolution apparatus II, Veego using 500 
ml 0.1 N HCl as 
When emulsion of Na-alginate & Metronidazole with sunflower oil 
was dropped into calcium chloride solutions, spherical gel beads 
were then formed instantaneously due to intermolecular cross-
linking between the divalent calcium ions and the negatively 
charged carboxyl group of alginic acid. Freshly prepared beads 
containing sunflower oil were almost spherical and white(Fig. 1) 
which after drying become brownish and dense(Fig. 2). Brown 
colour is due to the original color of sunflower oil. 
a dissolution medium maintained at 37±0.5°C. Beads 
equivalent to 10mg of the pure drug were used for the study. A 2 ml 
of the aliquot was withdrawn at predetermined intervals and 
replaced with fresh dissolution medium. The aliquots were further 
diluted suitably and analyzed at 272.5 nm using UV-1700, 
SHIMADZU spectrophotometer. 
RESULTS AND DISCUSSION 
 
 
Fig. 1: Photograph of freshly prepared beads 
 
 
Fig. 2: Photograph of dried beads 
 
Bead size 
The average size of the dried spherical beads ranged from 1.954 mm 
to 2.064 mm(Table 2) depending on the concentration of the 
polymer and sunflower oil used. Size of the beads increases with the 
increase in the concentration of polymer at 10% fixed concentration 
of calcium chloride. This may be due to the increase in the viscosity 
of the polymer solution that in turn increases the droplet size during 
addition of the polymer solution to the cross-linking solution. It was 
also found that, if pressure is increased in the piston during ejection 
of slurry, the beads sizes are increased. 
Entrapment Efficiency 
Drug entrapment efficiency ranged from 76% to 84%(Table 2). It 
was observed that an increase in the amount of polymer increases 
drug entrapment efficiency due to increased space for drug 
molecules to be retained throughout a larger cross linked network of 
calcium alginate. It was also observed that increasing of the curing 
time decrease the drug entrapment efficiency which may be due to 
the solubility of Metronidazole in water. 
 
Table 2: Physicochemical characterization of the prepared beads 
Formulation 
No. 








F1 1.998 76.8712 187 >24 
F2 1.954 79.0245 156 >24 
F3 2.064 81.0231 179 >24 





All formulations floated within 187 seconds (Table 2) after being 
placed into the acidic medium (0.1 N HCl) and remained buoyant in 
the medium throughout the study irrespective of polymer and oil 
concentration. Primarily, sunflower oil entrapped in the bead is 
responsible for floating i. e. oil acts as floating aid. Secondarily 
during dissolution, drug released from the matrix of the beads and 
swelling reduces the bulk density, which also aid to float the beads. 
Morphology 
SEM study of alginate beads showed spherical morphology with 
small pores or minute channels (Fig.3). Small pocket structures 
(Fig.4) are found on the cross sectional area of the interior part of 
the beads i. e., matrix of the beads which prove that oil was 
entrapped in the alginate matrix. 
 
 
Fig. 3: SEM image of drug & oil incorporated alginate bead 
 
 
Fig. 4: SEM image of cross section of drug & oil incorporated 
alginate bead. 
 
In vitro drug release 
Different batches of the formulation were able to release up to about 
(92 to 98)% drug after 6 hours under study(Table 3). From the 
release profile, it was observed that the drug release kinetics was 
best fitted with the Higuchi model(Fig.5). From the results of 
correlation coefficients and release exponent data of different 
batches using the Korsemeyer–Peppas model, it was observed that 
the drug release from the polymer matrix system was non fickian 
(anomalous transport) type (1<n< 0.5) (Table 4). Anomalous 
transport or non-fickian diffusion refers to combinations of both 
diffusion and erosion controlled rate release. The initial fast release 
was attributed to the diffusion of the adsorbed drug particles on or 
near the outer surface of the beads, while subsequent release was 
due to slow diffusion of the entrapped drug from the interior core of 
the alginate matrix. 
Table 3: Cumulative % drug release of different batches at different times(n=5). 
Time 
(Hrs) 
Cumulative % Release 
F1 F2 F3 F4 
0 0 0 0 0 
0.5 60±2.49 59.375±0.61 67.5±1.85 61.25±2.55 
1 68.6375±3.98 68.0075±1.68 71.1775±2.67 64.8775±2.13 
2 72.0475±2.52 68.905±3.15 77.735±2.51 75.8025±2.51 
3 77.98±2.65 78.59±2.44 80.5525±3.11 72.3375±2.47 
4 79.5425±3.51 83.92±1.99 84.0075±2.74 77.6425±1.95 
5 89.2675±2.50 88.015±2.36 86.22±2.19 80.4575±2.06 
6 97.775±4.12 98.4±2.09 92.8325±1.57 94.5775±2.10 
 
 
Fig. 5: Higuchi model of drug release for all formulations. 
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Table 4: Results of correlation coefficients and diffusion exponent for the drug release. 
Formulation No. Correlation Coefficients(R2 Model of best fit ) Diffusion exponent (n) Release mechanism 
Zero order First order Higuchi 
F1 0.625 0.834 0.837 Higuchi 0.727 Anomalous transport 
F2 0.647 0.825 0.854 Higuchi 0.738 Anomalous transport 
F3 0.508 0.823 0.752 Higuchi 0.685 Anomalous transport 
F4 0.567 0.777 0.789 Higuchi 0.699 Anomalous transport 
 
CONCLUSION 
The designed formulations of Metronidazole combining an excellent 
buoyant ability and suitable drug release pattern could possibly be 
advantageous in terms of stomach targeting. We found that all of the 
formulations floated more than 24 hours with the minimum lag 
time. The longer residence time of dosage forms can maintain a 
higher metronidazole concentration in the gastric region where H. 
pylori exists, will allow more of the drug to penetrate through the 
gastric mucus layer to act on H. pylori and thereby improve the 
therapeutic efficacy of Metronidazole. 
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